EUVIMEDEUVIMED entdecken
Open Access

Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria

Alyssa Hochberg, Michael H Dahan, Hakan Yarali, Lan N Vuong, Sandro C Esteves

Journal of Assisted Reproduction and Genetics · 2024

DOI: 10.1007/s10815-024-03296-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von Alyssa Hochberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, McGill University, 845 Rue Sherbrooke, O, Montreal, QC, 3HA 0G4, Canada. alyssahoch@gmail.com. Hauptthemen laut MEDLINE: Ovulation Induction, Follicle Stimulating Hormone, Fertilization in Vitro, Anti-Mullerian Hormone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The purpose of this study is to investigate the impact of daily follicle-stimulating-hormone (FSH) dose on the likelihood of suboptimal response to ovarian stimulation (OS) for in vitro fertilization (IVF) according to POSEIDON's criteria. METHODS: A tri-center retrospective cohort study (2015-2017) including women with normal anti-Müllerian hormone (AMH ≥ 1.2 ng/mL) and antral follicle count (AFC ≥ 5) values per POSEIDON's criteria, undergoing their first IVF/ICSI cycle using conventional OS (FSH ≥ 150 IU/day). Suboptimal response was the retrieval of 4-9 oocytes. In previous research, we detected an AMH ≤ 2.97 ng/mL and AFC ≤ 12 as the optimal cut-offs predicting suboptimal response. Therefore, we examined the effect of daily FSH dose (≤ 300 IU versus > 300 IU) on suboptimal response risk for each AMH and AFC value within these thresholds (AMH between 1.20 and 2.97 ng/mL, by 0.01 ng/mL increments; and an AFC between 5 and 12, by unit increments). Analysis involved contingency tables and multivariable logistic regression. RESULTS: Included were 4005 patients with AMH and AFC values in the specific range, among whom 2131 (53.2%) were suboptimal responders. Among 177 AMH groups analyzed, apart from three distributed irregularly, daily FSH doses > 300 IU versus lower doses (≤ 300 IU) did not decrease suboptimal response risk; similarly, higher doses did not decrease risk at the eight AFC values examined (p > 0.05 for all). Using multivariable logistic regression, FSH doses were not associated with suboptimal response risk. Conversely, female age, AMH, AFC, and gonadotropin type were associated with suboptimal response. CONCLUSIONS: In women with AMH values between 1.20 and 2.97 ng/mL and/or AFC between 5 and 12, FSH dose increase did not decrease suboptimal response risk. Individualizing the gonadotropin regimen and considering LH activity supplementation to FSH may mitigate risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionFollicle Stimulating HormoneFertilization in VitroAnti-Mullerian HormoneOvarian FollicleHumansFemaleAdultPregnancyRetrospective StudiesPregnancy RateOocyte RetrievalOocytesSperm Injections, Intracytoplasmic

Stichwörter der Autor:innen

Follicle-stimulating hormone doseOocyte yieldPOSEIDON criteriaSuboptimal ovarian response

Substanzen

Follicle Stimulating HormoneAnti-Mullerian Hormone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, McGill University, 845 Rue Sherbrooke, O, Montreal, QC, 3HA 0G4, Canada. alyssahoch@gmail.com.
  • The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. alyssahoch@gmail.com.
  • Department of Obstetrics and Gynecology, McGill University, 845 Rue Sherbrooke, O, Montreal, QC, 3HA 0G4, Canada.
  • Anatolia IVF, Ankara, Turkey.
  • Department of Obstetrics and Gynecology, Hacettepe University, Ankara, Turkey.
  • Department of Obstetrics and Gynecology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Zitieren

APA

Hochberg, A., Dahan, M. H., Yarali, H., Vuong, L. N., & Esteves, S. C. (2024). Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03296-2

Vancouver

Hochberg A, Dahan MH, Yarali H, Vuong LN, Esteves SC. Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria. Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03296-2

BibTeX
@article{Hochberg2024,
  author = {Hochberg, Alyssa and Dahan, Michael H and Yarali, Hakan and Vuong, Lan N and Esteves, Sandro C},
  title = {Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria},
  journal = {Journal of Assisted Reproduction and Genetics},
  year = {2024},
  doi = {10.1007/s10815-024-03296-2}
}
Kostenlos starten →